BLOOD CANCER February 17, 2025 by Marisa Wexler, MS Tuspetinib as part of triple-combo therapy showing potential in AML A triple-combination therapy using tuspetinib, Aptose Biosciences‘…
BLOOD CANCER February 10, 2025 by Marisa Wexler, MS Cancer vaccine galinpepimut-S may improve AML survival: Analysis Treatment with the cancer vaccine galinpepimut-S (GPS) is showing…
BLOOD CANCER February 3, 2025 by Lindsey Shapiro, PhD Blincyto approved in Europe for newly diagnosed adults with B-ALL The European Commission has approved Blincyto (blinatumomab) as…